Riskpilot← Back to searchSign inGet full accessHelmedici AB
ABActiveOrg 5590126693Tallrotsgatan 25 Lgh1301General medical practice activities · NACE 8621Est. 20152 employees
Revenue 2025
SEK 3,8M
+2% vs 2024
EBITDA margin
44.4%
+13% vs 2024
Equity ratio
57.8%
Financial strength
Net profit 2025
SEK 1,3M
+20% vs 2024
| Revenue | SEK 3,8M | +2% |
| EBITDA | SEK 1,7M | +13% |
| Net profit | SEK 1,3M | +20% |
| Total assets | SEK 7M | +14% |
| Equity | SEK 4,1M | +23% |
| Employees | 2 | — |
Legal name
Helmedici AB
Org number
5590126693
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 maj 2015
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva läkartjänster samt därmed förenlig verksamhet. Bolaget skall äga och förvalta fastigheter och bostäder samt därmed liknande fast och lös egendom.
Address
Tallrotsgatan 25 Lgh1301
Email
helmediciab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 851 | 3 480 | 3 603 | 3 723 | 3 801 |
| Staff expenses | — | 49 | −1 650 | −1 742 | −1 848 |
| EBITDA | 590 | 3 206 | 1 526 | 1 495 | 1 688 |
| Depreciation & amort. | −69 | — | −3 | −32 | −32 |
| EBIT | 521 | 3 206 | 1 523 | 1 463 | 1 656 |
| Net financials | −1 | −352 | 255 | 102 | 4 |
| Profit before tax | 469 | 2 465 | 1 410 | 1 353 | 1 620 |
| Tax | −367 | −258 | −250 | −291 | −348 |
| Net profit | 102 | 2 206 | 1 160 | 1 061 | 1 272 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 115 | 4 413 | 5 419 | 6 173 | 7 030 |
| Equity | 594 | 2 261 | 2 856 | 3 301 | 4 060 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 593 | 414 | 457 | 554 | 613 |
| Total debt | 593 | 414 | 457 | 554 | 613 |
EBITDA margin
44.4%
This company
15.8%
Market median
+181% vs market
20212025
Equity ratio
57.8%
This company
38.2%
Market median
+51% vs market
20212025
Return on equity
31.3%
This company
18.4%
Market median
+70% vs market
20212025
Net profit margin
33.5%
This company
8.1%
Market median
+314% vs market
20212025
Asset turnover
0.54×
This company
1.12×
Market median
-52% vs market
20212025
Debt / equity
0.73×
This company
0.62×
Market median
+18% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JO | Audit | 2022 |
IE Auditor Substitute | Auditor Substitute | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Helmedici AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Joakim Olof Ragnar Lindblad | Audit | 0 companies |
| Inger Elisabeth Edling | Auditor Substitute | 0 companies |
| Andrzej Feliks Helminiak | Board of Directors | 0 companies |
| Iwona Maria Helminiak | Deputy Board Member | 0 companies |